Dow Up 0.51% Nasdaq Up 0.24%

OncoMed Pharmaceuticals, Inc. (OMED)

-NasdaqGS
21.27 Down 0.36(1.66%) Nov 21, 4:00PM EST
Prev Close:21.63
Open:21.99
Bid:21.24 x 900
Ask:21.28 x 500
1y Target Est:40.67
Beta:1.637
Next Earnings Date:N/A
Day's Range:21.08 - 22.00
52wk Range:12.50 - 42.34
Volume:109,260
Avg Vol (3m):168,323
Market Cap:634.53M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for OMED

Comparison

Symbol% ChgMkt Cap
OMEDDown 1.66%634.53M
STMLDown 0.50%181.43M
VSTMUp 1.36%231.23M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):12.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.46
Quarterly EPS Est (Dec-14) :-0.28
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

OncoMed Pharmaceuticals, Inc., a clinical development-stage biotechnology company, focuses on discovering and developing monoclonal antibody therapeutics targeting cancer stem Cells (CSCs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback